![Kevin Trapp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Trapp
Corporate Officer/Principal presso
DBV TECHNOLOGIES
Profilo
Kevin Trapp is currently Chief Commercial Officer at DBV Technologies SA since 2025.
Formerly, Mr. Trapp was Senior Vice President-Portfolio & Access Strategy at Bristol Myers Squibb Co. from 2014 to 2016 and Chief Commercial Officer at DBV Technologies SA from 2018 to 2020.
Mr. Trapp completed undergraduate education at the University of Connecticut School of Business.
Posizioni attive di Kevin Trapp
| Società | Posizione | Inizio |
|---|---|---|
| DBV TECHNOLOGIES | Corporate Officer/Principal | 03/11/2025 |
Precedenti posizioni note di Kevin Trapp
| Società | Posizione | Fine |
|---|---|---|
| DBV TECHNOLOGIES | Corporate Officer/Principal | 02/10/2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/06/2016 |
Formazione di Kevin Trapp
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
71
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
University of Connecticut School of Business
 University of Connecticut School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
